Yan HH - Search Results

1

Gefitinib Versus Vinorelbine Plus Cisplatin as Adjuvant Treatment for Stage II-IIIA (N1-N2) EGFR-Mutant NSCLC: Final Overall Survival Analysis of CTONG1104 Phase III Trial.

Zhong WZ, Wang Q, Mao WM, Xu ST, Wu L, Wei YC, Liu YY, Chen C, Cheng Y, Yin R, Yang F, Ren SX, Li XF, Li J, Huang C, Liu ZD, Xu S, Chen KN, Xu SD, Liu LX, Yu P, Wang BH, Ma HT, Yang JJ, Yan HH, Yang XN, Liu SY, Zhou Q, Wu YL. Zhong WZ, et al. Among authors: yan hh. J Clin Oncol. 2021 Mar 1;39(7):713-722. doi: 10.1200/JCO.20.01820. Epub 2020 Dec 17. J Clin Oncol. 2021. PMID: 33332190 Free PMC article. Clinical Trial.

2

RRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy.

Dong S, Guo AL, Chen ZH, Wang Z, Zhang XC, Huang Y, Xie Z, Yan HH, Cheng H, Wu YL. Dong S, et al. Among authors: yan hh. J Hematol Oncol. 2010 Mar 13;3:10. doi: 10.1186/1756-8722-3-10. J Hematol Oncol. 2010. PMID: 20226083 Free PMC article.

3

Posttreatment plasma VEGF levels may be associated with the overall survival of patients with advanced non-small cell lung cancer treated with bevacizumab plus chemotherapy.

An SJ, Huang YS, Chen ZH, Su J, Yang Y, Chen JG, Yan HH, Lin QX, Yang JJ, Yang XN, Zhou Q, Zhang XC, Wu YL. An SJ, et al. Among authors: yan hh. Med Oncol. 2012 Jun;29(2):627-32. doi: 10.1007/s12032-011-9924-x. Epub 2011 Apr 3. Med Oncol. 2012. PMID: 21461966

4

[Forecasting model of risk of cancer in lung cancer pedigree in a case-control study].

Lin H, Zhong W, Yang X, Yan H, Wu Y. Lin H, et al. Zhongguo Fei Ai Za Zhi. 2011 Jul;14(7):581-7. doi: 10.3779/j.issn.1009-3419.2011.07.04. Zhongguo Fei Ai Za Zhi. 2011. PMID: 21762627 Free PMC article. Chinese.

5

Relative abundance of EGFR mutations predicts benefit from gefitinib treatment for advanced non-small-cell lung cancer.

Zhou Q, Zhang XC, Chen ZH, Yin XL, Yang JJ, Xu CR, Yan HH, Chen HJ, Su J, Zhong WZ, Yang XN, An SJ, Wang BC, Huang YS, Wang Z, Wu YL. Zhou Q, et al. Among authors: yan hh. J Clin Oncol. 2011 Aug 20;29(24):3316-21. doi: 10.1200/JCO.2010.33.3757. Epub 2011 Jul 25. J Clin Oncol. 2011. PMID: 21788562

6

Is ¹⁸F-fluorodeoxyglucose positron emission tomography-based metabolic response superior to Response Evaluation Criteria In Solid Tumors-based response after two cycles of platinum-based chemotherapy in predicting clinical outcome of untreated patients with advanced non-small cell lung cancer?

Yang JJ, Wang SX, Zhong WZ, Xu CR, Yan HH, Wu YL. Yang JJ, et al. Among authors: yan hh. Nucl Med Commun. 2011 Dec;32(12):1113-20. doi: 10.1097/MNM.0b013e32834a8341. Nucl Med Commun. 2011. PMID: 21934546

7

[High resolution melting analysis for detecting p53 gene mutations in patients with non-small cell lung cancer].

Chen Z, An S, Xie Z, Yan H, Chen J, Su J, Zhang X, Niu F, Guo W, Wu Y. Chen Z, et al. Zhongguo Fei Ai Za Zhi. 2011 Oct;14(10):767-73. doi: 10.3779/j.issn.1009-3419.2011.10.01. Zhongguo Fei Ai Za Zhi. 2011. PMID: 22008105 Free PMC article. Chinese.

8

EGFR mutation heterogeneity and the mixed response to EGFR tyrosine kinase inhibitors of lung adenocarcinomas.

Chen ZY, Zhong WZ, Zhang XC, Su J, Yang XN, Chen ZH, Yang JJ, Zhou Q, Yan HH, An SJ, Chen HJ, Jiang BY, Mok TS, Wu YL. Chen ZY, et al. Among authors: yan hh. Oncologist. 2012;17(7):978-85. doi: 10.1634/theoncologist.2011-0385. Epub 2012 Jun 6. Oncologist. 2012. PMID: 22673630 Free PMC article.

9

Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status.

An SJ, Chen ZH, Su J, Zhang XC, Zhong WZ, Yang JJ, Zhou Q, Yang XN, Huang L, Guan JL, Nie Q, Yan HH, Mok TS, Wu YL. An SJ, et al. Among authors: yan hh. PLoS One. 2012;7(6):e40109. doi: 10.1371/journal.pone.0040109. Epub 2012 Jun 29. PLoS One. 2012. PMID: 22768234 Free PMC article.

10

A clinical model to estimate the pretest probability of lung cancer, based on 1198 pedigrees in China.

Lin H, Zhong WZ, Yang XN, Zhang XC, Yang JJ, Zhou Q, Yan HH, Liao RQ, Nie Q, Dong S, Wu YL. Lin H, et al. Among authors: yan hh. J Thorac Oncol. 2012 Oct;7(10):1534-40. doi: 10.1097/JTO.0b013e3182641b82. J Thorac Oncol. 2012. PMID: 22982654 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

231 results

Search Page

Filters